Sakai, Japan

Michio Ishibashi

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2005.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michio Ishibashi: Innovator in Organ Damage Treatment

Introduction

Michio Ishibashi is a notable inventor based in Sakai, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of organ damage. His innovative approach focuses on developing drugs that prevent and treat progressive lesions without compromising organ function.

Latest Patents

Ishibashi holds a patent for "Selective preventives/remedies for progressive lesions after organ damage." This invention aims to provide drugs that selectively regulate the induction of cytotoxic effector macrophages in response to chemokines or cytokines. This targeted approach is crucial for treating damaged organ tissues effectively.

Career Highlights

Throughout his career, Ishibashi has demonstrated a commitment to advancing medical science. His work has led to the development of therapies that enhance organ recovery and regeneration. His innovative mindset has positioned him as a key figure in the medical research community.

Collaborations

Ishibashi has collaborated with esteemed colleagues, including Alain Wagner and Catherine Sylvain. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of organ damage treatment.

Conclusion

In summary, Michio Ishibashi is a pioneering inventor whose work in organ damage treatment has the potential to transform medical practices. His dedication to innovation and collaboration continues to inspire advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…